Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-875 Cardiovascular Outcomes Study in Type 2 Diabetes
NCT01609582Phase 3Terminated
- Sponsor
- Takeda
- Start
- Jun 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 32
01
Overview
A Phase 3 trial of fasiglifam in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Jun 2012; status: terminated.
02
Drugs
fasiglifam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01609582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01609582.